Provide a valuable resource to your clients or customers by linking to this resource page. Just place the following link on your website.
Lovenox is a prescription low molecular weight heparin containing enoxaparin sodium. It is used to prevent deep vein thrombosis in selected surgical and hospitalized medical patients, treat acute deep vein thrombosis with or without pulmonary embolism, and manage selected acute coronary syndromes. It is supplied in prefilled injection syringes and other injectable presentations.
read more about lovenox ...Enoxaparin increases the activity of antithrombin, which inhibits clotting factor Xa and, to a lesser degree, factor IIa. This reduces thrombin generation and the formation and extension of blood clots.
Lovenox is used for clot prevention after certain abdominal, hip, or knee procedures and during acute illness with severely restricted mobility. It also treats selected acute deep vein thrombosis and is used for unstable angina, non-Q-wave myocardial infarction, and ST-segment elevation myocardial infarction. Active major bleeding and recent heparin-induced thrombocytopenia are contraindications.
Dosing depends on the indication, body weight, kidney function, and care setting. Common adult prevention regimens include 40 mg subcutaneously once daily or 30 mg every 12 hours for certain orthopedic procedures. Acute deep vein thrombosis treatment commonly uses 1 mg per kg every 12 hours or, in selected hospitalized patients, 1.5 mg per kg once daily. Creatinine clearance below 30 mL per minute requires dose adjustment.
Lovenox carries a boxed warning for spinal or epidural hematomas during neuraxial anesthesia or spinal puncture, which can cause permanent paralysis. Other serious concerns include major bleeding, heparin-induced thrombocytopenia with or without thrombosis, and increased clotting risk in pregnant patients with mechanical prosthetic heart valves. Blood counts, platelets, kidney function, and signs of bleeding are monitored.
Lovenox prevents or treats certain blood clots and is used in selected unstable angina and heart attack treatment regimens.
Most labeled regimens use subcutaneous injection, while some acute heart attack regimens also use intravenous administration.
No. Doses vary by prevention versus treatment, weight, kidney function, procedure, and heart attack setting.
Yes. Its boxed warning concerns spinal or epidural hematomas that can result in long-term or permanent paralysis.
DailyMed - LOVENOX (enoxaparin sodium) injection. https://www.dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=5017a927-2a24-4f27-89f9-27c805bf7d59. Date Accessed October 13, 2026.
Enoxaparin. Drugs and Lactation Database (LactMed). https://www.ncbi.nlm.nih.gov/books/NBK500600/. Date Accessed October 13, 2026.
Enoxaparin Injection. MedlinePlus. https://www.medlineplus.gov/druginfo/meds/a601210.html. Date Accessed October 13, 2026.
Enoxaparin. PubChem. https://pubchem.ncbi.nlm.nih.gov/compound/Enoxaparin. Date Accessed October 13, 2026.
Enoxaparin. StatPearls. https://www.ncbi.nlm.nih.gov/books/NBK539865/. Date Accessed October 13, 2026.